{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:07:07Z","timestamp":1771567627031,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T00:00:00Z","timestamp":1374624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s10072-013-1481-y","type":"journal-article","created":{"date-parts":[[2013,7,23]],"date-time":"2013-07-23T04:45:38Z","timestamp":1374554738000},"page":"215-220","source":"Crossref","is-referenced-by-count":25,"title":["The complement and immunoglobulin levels in NMO patients"],"prefix":"10.1007","volume":"35","author":[{"given":"Ying","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai Ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya Qing","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng Qi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue Qiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,24]]},"reference":[{"issue":"8","key":"1481_CR1","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneurol.2009.152","volume":"66","author":"SM Magana","year":"2009","unstructured":"Magana SM et al (2009) Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease. Arch Neurol 66(8):964\u2013966","journal-title":"Arch Neurol"},{"issue":"6","key":"1481_CR2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","volume":"11","author":"MC Papadopoulos","year":"2012","unstructured":"Papadopoulos MC, Verkman AS (2012) Aquaporin 4 and neuromyelitis optica. Lancet Neurol 11(6):535\u2013544","journal-title":"Lancet Neurol"},{"issue":"Pt 7","key":"1481_CR3","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti CF et al (2002) A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain 125(Pt 7):1450\u20131461","journal-title":"Brain"},{"issue":"12","key":"1481_CR4","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1212\/01.WNL.0000148481.80152.BF","volume":"63","author":"J Correale","year":"2004","unstructured":"Correale J, Fiol M (2004) Activation of humoral immunity and eosinophils in neuromyelitis optica. Neurology 63(12):2363\u20132370","journal-title":"Neurology"},{"issue":"3B","key":"1481_CR5","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1590\/S0004-282X2007000500013","volume":"65","author":"B Padilla-Docal","year":"2007","unstructured":"Padilla-Docal B et al (2007) C3c intrathecal synthesis evaluation in patients with multiple sclerosis. Arq Neuropsiquiatr 65(3B):800\u2013802","journal-title":"Arq Neuropsiquiatr"},{"issue":"Suppl 5","key":"1481_CR6","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1007\/s10072-003-0170-7","volume":"24","author":"W Bruck","year":"2003","unstructured":"Bruck W, Stadelmann C (2003) Inflammation and degeneration in multiple sclerosis. Neurol Sci 24(Suppl 5):S265\u2013S267","journal-title":"Neurol Sci"},{"issue":"10","key":"1481_CR7","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.4049\/jimmunol.165.10.5867","volume":"165","author":"S Nataf","year":"2000","unstructured":"Nataf S et al (2000) Attenuation of experimental autoimmune demyelination in complement-deficient mice. J Immunol 165(10):5867\u20135873","journal-title":"J Immunol"},{"issue":"4","key":"1481_CR8","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1073\/pnas.1109980108","volume":"109","author":"SR Hinson","year":"2012","unstructured":"Hinson SR et al (2012) Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci USA 109(4):1245\u20131250","journal-title":"Proc Natl Acad Sci USA"},{"key":"1481_CR9","first-page":"862169","volume":"2012","author":"M Kinoshita","year":"2012","unstructured":"Kinoshita M, Nakatsuji Y (2012) Where do AQP4 antibodies fit in the pathogenesis of NMO? Mult Scler Int 2012:862169","journal-title":"Mult Scler Int"},{"key":"1481_CR10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","volume":"8","author":"S Mader","year":"2011","unstructured":"Mader S et al (2011) Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 8:184","journal-title":"J Neuroinflammation"},{"issue":"10","key":"1481_CR11","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM et al (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485\u20131489","journal-title":"Neurology"},{"key":"1481_CR12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.0105-2896.2004.0123.x","volume":"198","author":"T Fujita","year":"2004","unstructured":"Fujita T, Matsushita M, Endo Y (2004) The lectin-complement pathway\u2013its role in innate immunity and evolution. Immunol Rev 198:185\u2013202","journal-title":"Immunol Rev"},{"issue":"2\u20133","key":"1481_CR13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1385\/IR:27:2-3:367","volume":"27","author":"D Mastellos","year":"2003","unstructured":"Mastellos D et al (2003) Complement: structure, functions, evolution, and viral molecular mimicry. Immunol Res 27(2\u20133):367\u2013386","journal-title":"Immunol Res"},{"issue":"14","key":"1481_CR14","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","volume":"344","author":"MJ Walport","year":"2001","unstructured":"Walport MJ (2001) Complement. First of two parts. N Engl J Med 344(14):1058\u20131066","journal-title":"N Engl J Med"},{"issue":"2","key":"1481_CR15","first-page":"256","volume":"29","author":"B Zhang","year":"2008","unstructured":"Zhang B et al (2008) Correlation between serum thyroxine and complements in patients with multiple sclerosis and neuromyelitis optica. Neuro Endocrinol Lett 29(2):256\u2013260","journal-title":"Neuro Endocrinol Lett"},{"key":"1481_CR16","doi-asserted-by":"crossref","first-page":"439018","DOI":"10.1155\/2012\/439018","volume":"2012","author":"PD Gorevic","year":"2012","unstructured":"Gorevic PD (2012) Rheumatoid factor, complement, and mixed cryoglobulinemia. Clin Dev Immunol 2012:439018","journal-title":"Clin Dev Immunol"},{"issue":"5","key":"1481_CR17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.bor.0000172799.03379.86","volume":"17","author":"DR Karp","year":"2005","unstructured":"Karp DR (2005) Complement and systemic lupus erythematosus. Curr Opin Rheumatol 17(5):538\u2013542","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"1481_CR18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/039463201102400209","volume":"24","author":"G Muzio Di","year":"2011","unstructured":"Di Muzio G et al (2011) Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment. Int J Immunopathol Pharmacol 24(2):357\u2013366","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"1481_CR19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brainresrev.2005.12.002","volume":"52","author":"SR Barnum","year":"2006","unstructured":"Barnum SR, Szalai AJ (2006) Complement and demyelinating disease: no MAC needed? Brain Res Rev 52(1):58\u201368","journal-title":"Brain Res Rev"},{"issue":"2","key":"1481_CR20","first-page":"131","volume":"31","author":"M Cojocaru","year":"1993","unstructured":"Cojocaru M, Serbanescu A, Cojocaru IM (1993) Changes of serum complement and of circulating immune complexes in patients with multiple sclerosis. Rom J Intern Med 31(2):131\u2013137","journal-title":"Rom J Intern Med"},{"issue":"7","key":"1481_CR21","first-page":"757","volume":"54","author":"H Tsukamoto","year":"2006","unstructured":"Tsukamoto H, Horiuchi T (2006) Clinical aspects of the complement system. Rinsho Byori 54(7):757\u2013762","journal-title":"Rinsho Byori"},{"issue":"3","key":"1481_CR22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H et al (2000) Inflammation and Alzheimer\u2019s disease. Neurobiol Aging 21(3):383\u2013421","journal-title":"Neurobiol Aging"},{"issue":"24","key":"1481_CR23","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","volume":"69","author":"SR Hinson","year":"2007","unstructured":"Hinson SR et al (2007) Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 69(24):2221\u20132231","journal-title":"Neurology"},{"issue":"Pt 2","key":"1481_CR24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","volume":"133","author":"S Saadoun","year":"2010","unstructured":"Saadoun S et al (2010) Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133(Pt 2):349\u2013361","journal-title":"Brain"},{"issue":"1\u20132","key":"1481_CR25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jneuroim.2009.07.014","volume":"215","author":"L Sabater","year":"2009","unstructured":"Sabater L et al (2009) Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study. J Neuroimmunol 215(1\u20132):31\u201335","journal-title":"J Neuroimmunol"},{"issue":"9","key":"1481_CR26","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1001\/archneurol.2009.188","volume":"66","author":"SR Hinson","year":"2009","unstructured":"Hinson SR et al (2009) Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Arch Neurol 66(9):1164\u20131167","journal-title":"Arch Neurol"},{"issue":"5","key":"1481_CR27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1515\/CCLM.2010.127","volume":"48","author":"S Jarius","year":"2010","unstructured":"Jarius S et al (2010) Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders. Clin Chem Lab Med 48(5):659\u2013663","journal-title":"Clin Chem Lab Med"},{"issue":"9451","key":"1481_CR28","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364(9451):2106\u20132112","journal-title":"Lancet"},{"issue":"4","key":"1481_CR29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA et al (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202(4):473\u2013477","journal-title":"J Exp Med"},{"issue":"Pt 5","key":"1481_CR30","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","volume":"130","author":"T Misu","year":"2007","unstructured":"Misu T et al (2007) Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130(Pt 5):1224\u20131234","journal-title":"Brain"},{"issue":"9","key":"1481_CR31","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.biocel.2012.06.013","volume":"44","author":"J Ratelade","year":"2012","unstructured":"Ratelade J, Verkman AS (2012) Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies. Int J Biochem Cell Biol 44(9):1519\u20131530","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-013-1481-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-013-1481-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-013-1481-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T03:50:49Z","timestamp":1563508249000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-013-1481-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,24]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["1481"],"URL":"https:\/\/doi.org\/10.1007\/s10072-013-1481-y","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,24]]}}}